Solesis Medical Technologies

What Solesis Medical Technologies does

Solesis Medical Technologies is a privately held advanced biomaterials company headquartered in Telford, Pennsylvania, that designs and manufactures custom polymer, textile, bioresorbable, and hybrid components for medical device and biopharmaceutical applications. The company integrates textile engineering (knitting, braiding, weaving) with polymer processing (extrusion, coating, lamination, dip molding, thermoforming) and proprietary Hydralese® polymer chemistry — including HydraleseRx for controlled-release drug delivery, HydraleseTx for nucleic acid transfection, and HydraleseMT for medical device implantation enhancement — to serve three primary verticals: MedTech (vascular devices, structural heart, general surgery), Pharma (drug delivery and nucleic acid delivery), and Life Sciences (single-use solutions for cell and gene therapy, bioprocessing, and cryopreservation).

Solesis operates through four wholly-owned subsidiaries — Charter Medical (single-use solutions), Secant Group (biomaterials textiles), Polyzen (polymer film and coating, acquired November 2022), and Sanavita Medical — with 500+ employees across 7 manufacturing sites in the USA and Costa Rica. The company's technology infrastructure includes ISO-certified facilities, FDA-registered sites, and Class 7 and 8 cleanrooms supporting Class I, II, and III medical devices, with 50+ vascular device integrations and 6 FDA-approved CAR-T cell therapy integrations evidencing deep regulatory validation.

The business model combines contract development and manufacturing services, custom biomaterial component sales, single-use product sales, and licensing/royalty arrangements for proprietary polymer excipients, with quote-based pricing and direct enterprise sales to OEMs and medical device innovators. John Witkowski serves as President and CEO.

Name

Solesis Medical Technologies

Legal name

Solesis, LLC

Website

https://solesis.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

251–500 employees

Short description

Solesis Medical Technologies is a privately held advanced biomaterials company that designs and manufactures custom polymer, textile, bioresorbable, and hybrid components for medical device, pharmaceutical, and life sciences customers through integrated CDMO capabilities and proprietary Hydralese® polymer platforms.

Ownership category

akta.pro rank

Product category

Medical Device Components & Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

akta.pro secondary industries

Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC), Single-Use Systems Assembly & Consumables Manufacturing (Bags/Tubing/Assemblies) (HLAGAGAH), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Medical device components
• Biomaterial manufacturing
• Bioresorbable polymers
• Pharmaceutical drug delivery
• Single-use bioprocessing

Headquarters

HQ city

Perkasie

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Custom Biomaterial Components: Development and manufacturing of custom polymer and textile solutions for medical devices, delivery systems, and components sold directly to MedTech innovators and OEMs.
2. Drug Delivery Excipients: Supply of proprietary Hydralese polymer platforms as excipients for pharmaceutical drug delivery applications.
3. Single-Use Solutions: Sale of single-use polymer-based solutions for biological fluid handling, cell growth, and cryopreservation in life sciences and biomanufacturing.
4. Contract Development & Manufacturing: Product development services from feasibility through commercialization, including prototyping, process development, scale-up, and validation support.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Solesis is an advanced biomaterials company that develops and manufactures custom polymer, textile, bioresorbable, and hybrid components for medical devices, drug delivery systems, and single-use bioprocessing solutions. The company integrates textile engineering (knitting, braiding, weaving) with polymer processing (extrusion, coating, lamination, dip molding, thermoforming) and operates the proprietary Hydralese family of bioresorbable polymer platforms to serve MedTech innovators, pharmaceutical companies, and life sciences organizations from concept through commercialization.

Product overview

Solesis is an advanced biomaterials company offering applied biomaterial solutions through a unified platform that combines polymer, textile, bioresorbable, and hybrid technologies. The company's product portfolio centers on four core biomaterial platforms—Polymers, Textiles, Bioresorbables, and Hybrids—supplemented by the proprietary Hydralese® family of polymer technologies including Hydralese® Rx (controlled drug delivery), Hydralese® Tx (nucleic acid delivery/transfection), and Hydralese® MT (medical device implantation enhancement). Solesis operates across three primary market segments: MedTech (vascular and general surgery device solutions), Life Sciences (single-use solutions for biological fluid management, cell & gene therapy, and bioprocessing), and Pharma (drug delivery and nucleic acid delivery). The company delivers both standard off-the-shelf materials and fully customized solutions, supported by comprehensive engineering, product development, manufacturing, and packaging services.

Differentiator

Problem solved

Functional benefit

Brands

• Charter Medical: Single-use polymer-based solutions for biological fluid handling, cell growth, and cryopreservation supporting biopharmaceutical manufacturing
• Secant Group
• Polyzen
• Hydralese Rx
• Hydralese Tx

Products and services

• Polymers Custom polymer solutions including films, coatings, laminates, and extruded components that provide medical device sealing, barrier, and surface properties for MedTech OEMs and device manufacturers.
• Textiles Advanced biomedical textiles including woven, knit, and braided structures providing mechanical strength, flexibility, and controlled porosity for vascular and surgical devices.
• Bioresorbables Biodegradable and bioresorbable polymer materials designed to break down safely in the body over time, supporting tissue regeneration and temporary therapeutic functions in medical devices.
• Hybrids Integrated textile and polymer hybrid constructs combining the mechanical properties of textiles with sealing and surface properties of polymers for advanced medical device applications.
• Hydralese Rx

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• PolyzencoreStrategic or Co-development Partner · 2 November 2022Solesis acquired Polyzen, a company specializing in polymer science for medical and biopharmaceutical applications. Polyzen's polymer film and coating technologies expanded Solesis' capabilities in medical device and biopharmaceutical sectors, accelerating development of advanced biomaterials solutions.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Confluent Medical Technologies: Confluent manufactures specialty materials and engineered components (nitinol, polymer, and textile-based) for medical devices across vascular, structural heart, and general surgery — directly overlapping Solesis' biomaterial component offerings and OEM customer base.
• Biomerics: Biomerics is a medical device contract manufacturer specializing in polymers, bioresorbables, and interventional components for vascular and structural heart applications — directly comparable to Solesis' MedTech biomaterials and CDMO business.
• Putnam Plastics: Putnam Plastics manufactures precision medical plastic components and tubing for minimally invasive devices, including catheter and interventional applications — overlapping with Solesis' polymer processing and vascular offerings.
• Surmodics: Surmodics provides biomaterial coatings and drug-delivery surface technologies for medical devices and in vitro diagnostics — comparable to Solesis' polymer coatings and Hydralese drug-delivery capabilities.
• Nordson Medical: Nordson Medical provides component and tubing solutions for medical devices, including precision extrusion and fluid management components — directly comparable to Solesis' polymer processing and single-use medical component offerings.

Broad incumbents

• DSM Biomedical (dsm-firmenich): DSM Biomedical is a large specialty biomaterials supplier offering medical-grade polymers and resorbable materials to the same MedTech and pharma customers that Solesis serves, but as part of a much broader specialty chemicals portfolio.
• Evonik Health Care: Evonik's Health Care division supplies specialty polymers, bioresorbables, and excipients for medical devices and pharma — a much larger incumbent competing with Solesis' Hydralese polymer and CDMO offerings.
• Lubrizol Life Sciences: Lubrizol Life Sciences produces medical-grade polymers, excipients, and contract-manufactured drug-device combination products — comparable to Solesis' polymer and drug-delivery platform but at significantly larger scale.
• Integer Holdings: Integer Holdings is a large medical device contract manufacturer offering components and assemblies for vascular, cardiac, and surgical applications — a broader incumbent competing for similar OEM programs as Solesis.
• Avient: Avient supplies specialty polymer materials including medical-grade formulations and bioresorbables — a broader incumbent overlapping with Solesis' polymer materials business across MedTech and life sciences customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Solesis01

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Solesis Medical Technologies